Trading Window to close from 1 July 2026 for Q1 results
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Norris Medicines has informed BSE that the trading window for its securities will be closed for designated persons including promoters, directors, auditors, key managerial persons and their immediate relatives, starting Wednesday, 1 July 2026. The window will reopen 48 hours after the company declares its unaudited financial results for the quarter ending 30 June 2026. The board meeting date for approving these results will be announced later. Designated persons have been told not to buy, sell or pledge shares during this period.
Routine compliance filing. No insider trade disclosed. Signals upcoming Q1 results declaration; insiders barred from trading during blackout.